FDA
- Status: approved
combined fixed dose combination (combined fixed dose combination) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
International Union Against Tuberculosis and Lung Diseases is the originator. The local marketing authorisation holder may differ — check the official source linked above.